ENDOMEDIX

Endomedix s a privately held medical device start-up company. It develops a platform technology that uses natural biopolymers in aqueous solutions to form hydrogel medical devices in situ. The company has been awarded 6 Phase I Small Business Innovation Research grants from NIH, and has recently been awarded a $1.5 million Phase II SBIR grant by the National Institute of Neurological Disorders and Stroke.